Tag: Hatch-Waxman Act

22

Jun

Why Authorized Generics Are Rare: The Strategic Limits of Brand-Name Discounts

Why Authorized Generics Are Rare: The Strategic Limits of Brand-Name Discounts

Explore why authorized generics are rare. Learn how brand manufacturers use them strategically during patent exclusivity periods to control competition, impacting drug pricing and consumer choice.

VIEW MORE
7

Jun

Authorized Generics in Patent Litigation: Impact on Competition

Authorized Generics in Patent Litigation: Impact on Competition

Explore how authorized generics disrupt pharmaceutical competition. Learn about their impact on patent litigation, FTC regulations, and the Hatch-Waxman Act.

VIEW MORE
4

Jan

Hatch-Waxman Act: How It Shaped Generic Drug Access in the U.S.

Hatch-Waxman Act: How It Shaped Generic Drug Access in the U.S.

The Hatch-Waxman Act created the modern system for generic drug approval in the U.S., balancing innovation incentives with affordable access. It cut drug costs by billions but also opened doors to patent abuse.

VIEW MORE
9

Dec

Multiple Generics: How Competitors Enter After the First Generic Drug Launch

Multiple Generics: How Competitors Enter After the First Generic Drug Launch

After the first generic enters the market, a cascade of competitors follows, triggering steep price drops and supply shortages. Learn how patent rules, authorized generics, and manufacturing bottlenecks shape the chaotic race to sell the same drug.

VIEW MORE
20

Nov

Hatch-Waxman Act: How U.S. Law Made Generic Drugs Affordable and Accessible

Hatch-Waxman Act: How U.S. Law Made Generic Drugs Affordable and Accessible

The Hatch-Waxman Act revolutionized U.S. drug access by creating a fast, affordable path for generic drugs. It balances innovation with competition, saving billions annually and making medications accessible to millions.

VIEW MORE

Categories

Popular posts

Popular tags

Menu

© 2026. All rights reserved.